Diagnosis and Treatment of Ulcerative Colitis
Article information
J Korean Med Assoc. 2005;48(2):154-166
Publication date (electronic) : 2005 February 28
doi :
https://doi.org/10.5124/jkma.2005.48.2.154
Abstract
Ulcerative colitis is idiopathic, chronic inflammatory bowel disease occurring usually in the rectum and the lower part of the colon. Bloody diarrhea and abdominal pain are the common symptoms. The clinical course of the disease can be acute or chronic with unpredictable relapses and remissions. The definition of the distribution and pattern of disease is important for the establishment of treatment strategy in the active phase as well as for the maintenance of remission. The current therapies include 5-aminosalicylic acid (5-ASA), corticosteroids, and immunosuppressive agents.
Keywords: Ulcerative colitis; Inflammatory bowel disease; Diarrhea; 5-ASA; Corticosteroid
References
1. Miner PB Jr. In : Kirsner JB, ed. Clinical features, course, laboratory findings, and complications in ulcerative colitis. Inflammatory Bowel Disease 2000. 5th edth ed. Philadelphia: W.B. Saunders;
2. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997. 92204–201.
3. Yang SK. Current status and clinical characteristics of inflammatory bowel disease in Korea. Korean J Gastroenterol 2002. 401–14.
4. Kim JW, Kim CG, Kim HD, Kim BG, Chang DK, Song IS, et al. The trends of the incidence rates, short-term outcome of treatment and relapse rates of ulcerative colitis. Korean J Gastroenterol 2003. 4115–25.
5. Choi YS, Kim TI, Lee HG, Kim YG, Kim MK, Ok JH, et al. A clinical review of ulcerative colitis. Korean J Med 1998. 5417–23.
6. Park ER, Yang SG, Myung SJ, Kim YM, Park JB, Min YI, et al. Familial occurrence of ulcerative colitis in Korea. Korean J Gastroenterol 2000. 36770–774.
7. Nam SW, Yang SK, Jung HY, Shim KN, Cho BD, Min YI, et al. Appendectomy and the risk of developing ulcerative colitis: results after control of smoking factor. Korean J Gastroenterol 1998. 3255–60.
8. Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004. 1261518–1532.
9. Seo JK, Yeon KM, Chi JG. Inflammatory bowel disease in children: clinical, endoscopic, radiologic and histopathologic investigation. J Korean Med Sci 1992. 7221–235.
10. Suh CH, Lee CH, Lee J, Song CH, Lee CW, Lee SK, et al. Arthritic manifestations of inflammatory bowel disease. J Korean Med Sci 1998. 1339–43.
11. Choi KY. Endoscopic findings of ulcerative colitis. Korean J Gastrointest Endosc 1998. 19suppl. 47–54.
12. Son JM, Yang SK, Myung SJ, Kim YM, Kim HC, Min YI, et al. The diagnostic course of ulcerative colitis in Korea. Korean J Med 2001. 60444–447.
13. Hanauer SB. Medical therapy for ulcerative colitis 2004. Gastroenterology 2004. 1261582–1592.
14. Jani N, Regueiro MD. Medical therapy for ulcerative colitis. Gastroenterol Clin North Am 2002. 31147–166.
15. Lee DH, Lee JH, Park DY, Kim YJ, Hwang JH, Kim CY, et al. Experience of cyclosporine A therapy in severe ulcerative colitis refractory to steroid treatment. Korean J Gastroenterol 1997. 3058–65.
16. Yu CS, Kim HC, Yang SK, Min YI, Kim JC. Restorative proctocolectomy in 50 patients with ulcerative colitis. Korean J Gastroenterol 2002. 40379–385.
17. Park KJ, Park G. Analysis of the results of surgical treatment options for ulcerative colitis. J Korean Soc Coloproctol 1997. 1377–96.
18. Larson DW, Pemberton JH. Current concepts and controversies in surgery for IBD. Gastroenterology 2004. 1261611–1619.
Article information Continued
Copyright © 2005 Korean Medical Association
